Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enterocyte | 7 studies | 45% ± 12% | |
| goblet cell | 6 studies | 31% ± 12% | |
| epithelial cell | 5 studies | 40% ± 13% | |
| pancreatic A cell | 3 studies | 46% ± 26% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 4 studies | 21% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 87% | 15395.49 | 843 / 966 | 96% | 596.92 | 508 / 527 |
| pancreas | 99% | 266.59 | 326 / 328 | 79% | 197.15 | 140 / 178 |
| stomach | 81% | 879.55 | 289 / 359 | 95% | 495.78 | 271 / 286 |
| liver | 68% | 320.78 | 153 / 226 | 38% | 119.56 | 155 / 406 |
| kidney | 93% | 316.91 | 83 / 89 | 2% | 1.76 | 16 / 901 |
| lung | 68% | 51.98 | 392 / 578 | 24% | 82.91 | 279 / 1155 |
| prostate | 84% | 310.49 | 205 / 245 | 8% | 5.44 | 40 / 502 |
| esophagus | 11% | 16.67 | 153 / 1445 | 48% | 337.82 | 87 / 183 |
| spleen | 51% | 12.98 | 124 / 241 | 0% | 0 | 0 / 0 |
| uterus | 29% | 20.02 | 49 / 170 | 12% | 54.73 | 57 / 459 |
| adrenal gland | 40% | 93.10 | 104 / 258 | 0% | 0.23 | 1 / 230 |
| bladder | 5% | 13.81 | 1 / 21 | 26% | 130.23 | 133 / 504 |
| adipose | 31% | 9.41 | 368 / 1204 | 0% | 0 | 0 / 0 |
| breast | 29% | 61.91 | 135 / 459 | 1% | 0.48 | 7 / 1118 |
| skin | 19% | 13.29 | 338 / 1809 | 0% | 0.10 | 1 / 472 |
| peripheral blood | 18% | 64.83 | 163 / 929 | 0% | 0 | 0 / 0 |
| ovary | 14% | 4.27 | 26 / 180 | 0% | 0.28 | 2 / 430 |
| heart | 14% | 3.20 | 121 / 861 | 0% | 0 | 0 / 0 |
| thymus | 14% | 3.23 | 91 / 653 | 0% | 0 | 0 / 605 |
| blood vessel | 8% | 2.97 | 111 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 6% | 1.31 | 48 / 803 | 0% | 0 | 0 / 0 |
| brain | 5% | 1.44 | 144 / 2642 | 0% | 0.08 | 1 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 1.45 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030277 | Biological process | maintenance of gastrointestinal epithelium |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0042803 | Molecular function | protein homodimerization activity |
| Gene name | MUC13 |
| Protein name | Mucin-13 (MUC-13) (Down-regulated in colon cancer 1) Mucin 13, cell surface associated |
| Synonyms | DRCC1 RECC UNQ6194/PRO20221 |
| Description | FUNCTION: Epithelial and hemopoietic transmembrane mucin that may play a role in cell signaling. |
| Accessions | ENST00000616727.4 C9IZG1 ENST00000478191.1 Q9H3R2 |